When to See a Fertility Specialist: The 12-Month Rule and Its Exceptions

TL;DR

• Under 35: see a specialist after 12 months

• 35 to 39: see a specialist after 6 months

• 40 and above: seek evaluation immediately or within 3 months

• Skip the wait if you have irregular cycles, PCOS, endometriosis, prior pelvic surgery or infection, recurrent miscarriage, prior cancer treatment, family history of early menopause, or known male-factor concerns

• A semen analysis for the male partner should run in parallel, not later

If you are under 35 and have been trying to conceive for 12 months without success, that is when the American Society for Reproductive Medicine (ASRM) recommends seeing a fertility specialist. If you are 35 or older, the wait drops to 6 months. For women over 40, more immediate evaluation is advised. Several conditions skip the waiting period entirely: irregular cycles, PCOS, endometriosis, prior pelvic surgery, and known male-factor history. In India, where infertility affects roughly 15 percent of married couples per Indian Council of Medical Research (ICMR) estimates, the right time to seek help is also shaped by cycle regularity, your partner's history, and any prior pelvic or reproductive conditions.

When to see a fertility specialist: a quick comparison

What is the 12-month rule for seeing a fertility specialist?

The 12-month rule comes from ASRM's 2021 Committee Opinion on fertility evaluation, published in Fertility and Sterility. It states that evaluation should begin at 12 months in women under 35. The reason is statistical: about 80 percent of fertile couples conceive in the first six months, and roughly 85 percent within a year. After 12 months, the chance of spontaneous conception in any given month drops sharply.

The 12 months must be regular, unprotected intercourse. ASRM recommends intercourse every one to two days across the fertile window. If you have been using condoms intermittently or travelling apart, the clock effectively resets.

When should women over 35 see a fertility specialist?

ASRM recommends evaluation at 6 months for women aged 35 and over. Female age is the single most important predictor of fecundity, and relative fertility is roughly halved at age 40 compared with the late 20s. For women over 40, ASRM and the American College of Obstetricians and Gynecologists (ACOG) both recommend more immediate evaluation, often within 3 months. The reasoning is time, not pessimism: IUI and IVF take cycles to work, and ovarian reserve declines during the diagnostic phase.

What are the exceptions to the 12-month rule?

ASRM lists specific conditions where evaluation should begin without waiting:

• Irregular cycles, cycle length under 25 days, intermenstrual bleeding, oligomenorrhea, or amenorrhea

• Known or suspected uterine, tubal, or peritoneal disease, including endometriosis

• Known or suspected male subfertility

• Sexual dysfunction

• Conditions that may reduce ovarian reserve, such as prior chemotherapy, radiation, or FMR1 premutation carrier status

• Family history of early menopause (under 40)

How does PCOS change the timeline?

If you have a clinical PCOS diagnosis, or features such as cycles over 35 days, hirsutism, or acanthosis nigricans, do not wait 12 months. Ovulatory dysfunction accounts for up to 40 percent of female infertility per ASRM, and PCOS is the most common cause. First-line evaluation includes TSH, anti-Mullerian hormone (AMH), a transvaginal ultrasound for antral follicle count, and a screen for raised androgens. Ovulation induction with letrozole or clomiphene often follows.

When should the male partner get tested?

At the same time as the female evaluation, not after. ASRM is explicit that when a male partner is contributing to the pregnancy, evaluation of both partners should begin at the same time, with at least one semen analysis at the onset. ICMR data shows male factor contributes to roughly one-third of infertility cases in India. A semen analysis is inexpensive and produces results in days, so there is no clinical reason to delay it.

What does a fertility evaluation involve in India?

A first specialist visit in India typically includes a detailed cycle and obstetric history, a focused physical examination, and initial investigations. Per ASRM guidance and routine FOGSI practice, these usually include:

• Day 2 to 4 FSH, LH, oestradiol; or AMH at any cycle day for ovarian reserve

• TSH and prolactin if cycles are irregular

• Transvaginal pelvic ultrasound for uterine and ovarian assessment

• Hysterosalpingography (HSG) or saline infusion sonography for tubal patency

• Semen analysis for the male partner

ASRM emphasises a systematic workup starting with the least invasive tests. If those tests reveal a treatable cause, a range of fertility treatments for women is available, from ovulation induction through to IVF. Laparoscopy and advanced sperm function testing are not recommended unless specifically indicated.

What can you do while still trying naturally?

If you have not yet hit the 12-month or 6-month threshold, evidence-backed steps that support fertility include:

• Tracking ovulation using a Mylo Ovulation Calculator or a urinary LH-based Ovulation Test Kit, and timing intercourse every 1 to 2 days across the fertile window

• Stopping smoking and limiting alcohol, both linked by ASRM to reduced fecundity

• Keeping BMI in a healthy range; ASRM links roughly 12 percent of infertility cases to being either overweight or underweight

• Starting preconception folate, ideally as L-methylfolate, at least 3 months before conception

Some women also choose a preconception supplement. Mylo's Ovaluna Female Fertility Capsules combine Shatavari (Asparagus racemosus, traditionally used in Ayurveda to support female reproductive health and cycle regulation), Coenzyme Q10 (involved in mitochondrial energy production within developing oocytes, with evolving evidence for supporting egg quality in older women), L-methylfolate (the bioactive folate form that bypasses the MTHFR enzyme step), zinc, B12, and vitamin D2. For a deeper look at how the formula is structured, see Mylo's own breakdown of Ovaluna tablet uses. Supplements are an adjunct, not a substitute. If you have hit the threshold or any exception applies, see a specialist regardless.

What does infertility actually look like in India?

A 2024 community-based study in peri-urban Ahmedabad (Indian Journal of Community Medicine) found a period prevalence of 7.4 percent (3.5 percent primary, 3.9 percent secondary). A 2026 systematic review in Reproductive Health pooled Indian studies between 1997 and 2023 and reported overall infertility at 8 percent. The ICMR's 13-district survey of 37,570 women estimated primary infertility at 4 percent urban and 3.7 percent rural. NFHS data shows secondary infertility rose from 19.5 percent in 1992-93 to 28.6 percent in 2015-16.

The takeaway is permission, not alarm. Infertility is common, evaluation is straightforward, and earlier is almost always better than later.

FAQs

How long should I wait before seeing a fertility doctor? Twelve months if you are under 35, six months if you are 35 or older, and immediately if you are over 40 or have any exceptional condition (irregular cycles, PCOS, endometriosis, prior pelvic surgery or infection, known male-factor history, recurrent miscarriage).

Does having irregular periods mean I am infertile? Not necessarily, but irregular cycles are an ASRM exception to the 12-month rule. Cycles consistently shorter than 25 days or longer than 35 days suggest ovulatory dysfunction and warrant evaluation regardless of how long you have been trying.

Should my husband also get tested? Yes, at the same time as your evaluation. ICMR data shows male factor contributes to roughly one-third of infertility cases in India. A semen analysis is the first and most informative test.

Is it too late to have a baby at 40? No, but evaluation should not be delayed. ASRM recommends more immediate evaluation for women over 40, and treatments such as IVF have lower per-cycle success rates with advancing age.

Can I take fertility supplements while still trying naturally? Yes. Preconception folate is recommended by every major guideline. Multi-ingredient supplements such as Ovaluna add Shatavari, CoQ10, zinc, and other nutrients linked to reproductive health. They are an adjunct, not a replacement for specialist evaluation once you hit the threshold.

Does pelvic tuberculosis affect fertility? Yes. India's high TB burden makes pelvic TB a recognised cause of tubal-factor infertility, often silent until imaging is done. If you have a personal or close family history, mention it at the first visit so tubal patency is checked early.

Disclaimer: This article is for general information and is not medical advice. Consult an obstetrician-gynaecologist or fertility specialist for personal guidance.

Medically reviewed by Dr. Shruti Tanwar, MBBS, MD (Obstetrics & Gynaecology) on 27 June 2026

Last updated: 30 June 2026

Sources

1. Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (2021). Fertil Steril 2021;116:1255-65.

2. Practice Committee of the American Society for Reproductive Medicine. Optimizing natural fertility: a committee opinion (2022). Fertil Steril.

3. ASRM. Defining Infertility patient education fact sheet. ReproductiveFacts.org.

4. American College of Obstetricians and Gynecologists. Infertility workup for the women's health specialist. ACOG Committee Opinion No. 781. Obstet Gynecol 2019;133:e377-84.

5. Hoda T, et al. Burden of Infertility, Its Risk Factors, Perceptions and Treatment-Seeking Behaviour Among Women of Reproductive Age Group: A Community-Based Cross-Sectional Study. Indian Journal of Community Medicine 2024;49:S46-S52.

6. Yadav K, et al. Primary and secondary infertility in India: a systematic review and meta-analysis. Reproductive Health 2026.

7. Katole A, Saoji AV. Causes and Prevalence of Factors Causing Infertility in a Public Health Facility. J Hum Reprod Sci 2019;12(4):287-293. (Cites the ICMR 13-district, 37,570-woman survey on primary infertility prevalence in urban and rural India.)

8. Kumar A, Sharma S. Surging trends of infertility and its behavioural determinants in India. PLOS ONE 2023;18(7):e0289096. (NFHS I-IV trend analysis showing secondary infertility rose from 19.5% to 28.6%, 1992-93 to 2015-16.)

9. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 2020;113:533-5.